Filing Details
- Accession Number:
- 0001213900-18-003691
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-29 18:00:36
- Reporting Period:
- 2018-03-28
- Accepted Time:
- 2018-03-29 18:00:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1506251 | Citius Pharmaceuticals Inc. | CTXR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1199080 | Z Myron Holubiak | C/O Citius Pharmaceuticals, Inc. 11 Commerce Drive, 1St Floor Cranford NJ 07016 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-28 | 2,915 | $3.09 | 519,882 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to Purchase Common Stock | $8.10 | 2025-10-01 | 26,667 | 26,667 | Direct | |
| Common Stock | Options to Purchase Common Stock | $3.45 | 2027-09-13 | 40,000 | 40,000 | Direct | |
| Common Stock | Warrant to Purchase Common Stock | $6.21 | 2019-06-12 | 19,615 | 19,615 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2025-10-01 | 26,667 | 26,667 | Direct |
| 2027-09-13 | 40,000 | 40,000 | Direct |
| 2019-06-12 | 19,615 | 19,615 | Direct |
Footnotes
- The option granted vested and became exercisable as follows: the option to purchase 2,667 shares of common stock of the Company (the "Common Stock") vested on October 1, 2015, and the balance of the option to purchase shares of Common Stock vested in twelve (12) equal installments commencing on December 31, 2015. The option was issued pursuant to the Company's 2014 Stock Incentive Plan.
- One-third of the shares of the Company's common stock underlying the grant vest on the first anniversary of the vesting commencement date, September 13, 2018. The remaining shares of the Company's common stock underlying the grant vest in equal monthly installments at the end of each month for two years following the initial vest, provided the Reporting Person continues to serve as a member of the Company's Board of Directors as of each such vesting date.
- The warrant is fully vested and exercisable immediately.
Billionaire Hedge Funds
